Correlation Between Invex Therapeutics and FSA
Can any of the company-specific risk be diversified away by investing in both Invex Therapeutics and FSA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Invex Therapeutics and FSA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Invex Therapeutics and FSA Group, you can compare the effects of market volatilities on Invex Therapeutics and FSA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Invex Therapeutics with a short position of FSA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Invex Therapeutics and FSA.
Diversification Opportunities for Invex Therapeutics and FSA
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Invex and FSA is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Invex Therapeutics and FSA Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FSA Group and Invex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Invex Therapeutics are associated (or correlated) with FSA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FSA Group has no effect on the direction of Invex Therapeutics i.e., Invex Therapeutics and FSA go up and down completely randomly.
Pair Corralation between Invex Therapeutics and FSA
Assuming the 90 days trading horizon Invex Therapeutics is expected to under-perform the FSA. In addition to that, Invex Therapeutics is 2.9 times more volatile than FSA Group. It trades about -0.27 of its total potential returns per unit of risk. FSA Group is currently generating about -0.17 per unit of volatility. If you would invest 84.00 in FSA Group on September 12, 2024 and sell it today you would lose (4.00) from holding FSA Group or give up 4.76% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Invex Therapeutics vs. FSA Group
Performance |
| Timeline |
| Invex Therapeutics |
| FSA Group |
Invex Therapeutics and FSA Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Invex Therapeutics and FSA
The main advantage of trading using opposite Invex Therapeutics and FSA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Invex Therapeutics position performs unexpectedly, FSA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FSA will offset losses from the drop in FSA's long position.| Invex Therapeutics vs. MetalsGrove Mining | Invex Therapeutics vs. Stelar Metals | Invex Therapeutics vs. Aurelia Metals | Invex Therapeutics vs. Dalaroo Metals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |